home / subscribe / donate / books / archives / search / links / feedback / events / faq
Special Double Issue Edition of Our Subscriber-Only Newsletter!
Hamas Chief on Israel’s Decline
Khaled Meshal talks to CounterPunch about Israel’s terrorism, Hamas’rockets and what Hamas will settle for. ALSO: What’s the body count from neoliberal terrorism in India? The largest wave of suicides in human history. India’s best journalist, P. Sainath, lays out the awful story. How did Harvard Law School behave in the McCarthy witch hunts? With sickening cowardice. Famed attorney Jonathan Lubell describes how the School tried to force him to testify and how the Harvard Law Review slammed the door in his face. What causes autism? Steven Higgs tracks the chemicals that may cause developmental disabilities. Alexander Cockburn honors one of England’s greatest environmental writers, the late Roger Deakin. Get your Legacy Edition today by subscribing online or calling 1-800-840-3683 Contributions to CounterPunch are tax-deductible. Click here to make a donation. If you find our site useful please: Subscribe Now! CounterPunch books and gear make great presents.
Order CounterPunch By Email For Only $35 a Year !
Note to Nation Readers:
For the Two Books for $30 Offer Call Us at 1-800-840-3683
|
Today's Stories January 14, 2009 Kathy Kelly January 13, 2009 Norman Finkelstein Jonathan Cook Michael Neumann Coleen Rowley / Robert Sandels Saul Landau David Swanson Wajahat Ali Sam Bahour Stanley Heller Robert Jensen Robin Mittenthal Website of the Day
January 12, 2009 Uri Avnery Paul Craig Roberts Mike Whitney Ewa Jasiewicz Bill Quigley Dave Lindorff Bill and Kathleen Christison Jonathan Cook Andy Worthington Kara N. Tina Brenda Norrell Nour Kharma Website of the Day
January 9/11, 2009 Alexander Cockburn Kathy Kelly Bill Quigley George Ciccariello-Maher Elaine C. Hagopian Mike Roselle Steve Hendricks Gary Leupp Jonathan Cook Karim Makdisi Rannie Amiri Peter Morici Peter Montague Ralph Nader Andy Worthington Nadia Hijab Dan Bacher Catherine Fenton David Macaray Valia Kaimaki Richard Morse David Yearsley Charles R. Larson Richard Rhames Stephen Martin Lorenzo Wolff Poets' Basement Website of the Weekend January 8, 2009 Jean Bricmont / Franklin Lamb Paul Craig Roberts Kevin Alexander Gray Chris Floyd Ewa Jasiewicz Steve Conn Harvey Wasserman Wayne S. Smith Linda Mamoun Adam Turl Chris Papaleonardos Website of the Day January 7, 2009 Saree Makdisi Franklin Lamb William Blum Belén Fernández Lawrence Davidson Allan Nairn Jonathan Cook Muhammad Idrees Ahmad Deepak Tripathi Cal Winslow Manuel Garcia, Jr. Dr. Hannah Safran Website of the Day January 6, 2009 Pam Martens Victoria Buch Neve Gordon Tami Sarfatti / Mike Whitney Alan Farago Gary Leupp Larry Everest Ron Jacobs David Macaray Stephanie Basile Stacey Warde Website of the Day January 5, 2009 Paul Craig Roberts Sousan Hammad Wajahat Ali Mats Svensson Jen Marlowe Muhammad Ali Khalidi Brian Cloughley Faheem Hussain William Cook Dr. Trudy Bond Christopher Ketcham Steve Early Dave Lindorff Website of the Day January 2 - 4, 2009 Alexander Cockburn Uri Avnery Jonathan Cook Paul Craig Roberts Brian Eno Ralph Nader Omar Barghouti Graham Usher P. Sainath Belén Fernández Deb Reich Gary Leupp Michael Yates Joanne Mariner Seth Sandronsky Cynthia McKinney Sonja Karkar Deepak Tripathi Robert Fantina John Ross Norm Kent Larry Portis Richard Rhames Dee C. Lubell David Yearsley Lorenzo Wolff Marc Catone Poets' Basement Website of the Weekend
January 1, 2008 Jennifer Loewenstein Oren Ben-Dor Wajahat Ali Saul Landau David Michael Green Website of the Day December 31, 2008 Pam Martens Neve Gordon / Ted Honderich Brian Cloughley Ron Jacobs Vijay Prashad Franklin Lamb Mike Whitney David Macaray Richard Thieme Mary Lynn Cramer Stephen Lendman Worthy Group of the Day December 30, 2008 Paul Craig Roberts Tariq Ali Robert Bryce Jonathan Cook Gary Leupp Dave Lindorff Brian McKenna John Walsh Ramzy Baroud Bob Sommer Worthy Activist of the Day
December 29, 2008 Jennifer Loewenstein Neve Gordon Joshua Frank George Salzman / Norman Solomon Ewa Jasiewicz Rob Larson Kenneth Libby Robert Weissman Elsa Johnson Nicola Nasser Belén Fernández Worthy Group of the Day December 26-28, 2008 Alexander Cockburn Dr Eyad Al Serraj Jeffrey St. Clair Bradley Simpson Ralph Nader Gary Leupp Ellen Cantarow Matt Landon David Macaray Patrick Bond Norm Kent Brian T. Ketcham Rannie Amiri Larry Portis Richard Rhames Stephen Lendman James L. Secor Ramzy Baroud Harold Pinter Cpt. Paul Watson Howard Lisnoff Michael Dee Steve Conn Poets' Basement Worthy Group of the Weekend December 25, 2008 Judy Gumbo Albert Rev. William E. Alberts Hannah Mermelstein Worthy Group of the Day December 24, 2008 Bill Quigley Saul Landau Sam Smith Brian Cloughley John Ross Eric Walberg Norm Kent Stephen Martin Worthy Group of the Day December 23, 2008 Michael Hudson Michael Yates Chuck Spinney Vijay Prashad Brian Horejsi David Macaray Neil Watkins / David Michael Green Worthy Group of the Day
|
January 14, 2009 Why Hold Up a Drug Just Because It's Dangerous?Fragile: Handle with RisperdalBy MARTHA ROSENBERG The email did not beat around the bush. "The rationale of this center," wrote Christine Cote, VP of Janssen's Medical Affairs about the planned MGH-Johnson & Johnson Center for the Study of Pediatric Psychopathology at Massachusetts General Hospital, "is to generate and disseminate data supporting the use of risperidone in this patient population." Okaaaaay. But even as postmortems are performed on the unholy alliance between Massachusetts General Hospital and Johnson & Johnson which surfaced last year, the drug giant is at it again. In January, Janssen Pharmaceutica N.V., a unit of Johnson & Johnson, announced it was funding a research venture at Vanderbilt University in Nashville, TN to discover "novel drugs for the treatment of schizophrenia," to be led by Jeffrey Conn, former head of Merck's department of neuroscience. Of course you can't blame J&J for seeking new academic stomping grounds. Its chief academic cheerleader, Harvard child psychiatrist Joseph Biederman, who headed its center at Mass Gen, has been benched for apparent psychopathology-for-pay schemes under which he increased the diagnosis of pediatric bipolar disorder fortyfold. Janssen is being sued by Texas, New Mexico and other states for hiding Risperdal dangers, marketing it for unapproved uses, ghostwriting, misleading doctors, falsifying science, kickback schemes and wholesale Medicaid fraud. And--Risperdal's US patent expired in 2008! Risperdal (risperidone), an atypical antipsychotic, may have contributed to the deaths of 31 childrensince its 1993 approval according to the New York Times--including 11 treated for unapproved uses; it may have squandered millions of tax dollars, but it is a branding success story. How else do you explain a drug for schizophrenia--1 per cent of the population--bipolar disorder--2.5 per cent--and autism-related irritability in children 5-16--less than 1 per cent of kids--becoming the seventh best selling med in the world in 2007? Of course some of Risperdal's success came from the award-winning "Living Nightmares" campaign by London-based ad agency Junction 11 which used Welsh artist Mark Moran's evocative oil paintings Dog-Woman, Witches, Rotting Flesh and Boiling Rain--get it?-- based on case histories to "own the relapse/prevention space" as art director John Timney put it. And don't forget the Prescribe Early campaign by ad agency Torre Lazur McCann which used a macabre abandoned wallet, teddy bear and keys on a barren street to "to reposition a drug that was being used too late to achieve its maximum benefits,"--look what happens when you wait!--according to Pharma Times magazine. Nor did the continuing medical education courses like "Individualizing ADHD Pharmacotherapy with Disruptive Behavioral Disorders" taught by the J&J funded Robert L. Findling and referring to Risperdol/risperdone 13 times hurt. Credit was available until 2009. But most of Risperdal's success comes from the unsung doctors--you know who you are--who extolled the drug for unapproved use in pediatric bipolar disorder, ADHD, depression, "agitated, expansive, grandiose" "psychopathologies" [per Biederman], Alzheimer's, jealousy, "oppositional" disorder, borderline states, assorted neurological diseases, sleep and mood disorders and whatever else would stick to the wall. Like the doctors who upheld the "long-term safety and effectiveness of risperidone for severe disruptive behaviors in children," on the basis of a one-year study in The Journal of the American Academy of Child and Adolescent Psychiatry in 2005. How else could a drug known to cause diabetes, obesity, breasts in men, lactation in women and the very tardive dyskinesia it was supposed to prevent be a first choice drug in state formularies and on Medicaid protocols? Given to children? How did it become a preferred nursing home treatment--Taylor Park Nursing and Rehabilitation Center resident Bruce Bowman in Rhinelander, WI died last June after being put on Risperdal reports the Milwaukee Journal Sentinel--despite a warning label that says it increases death in elderly patients with dementia-related psychosis? Nor did the FDA's why-hold-up-a-drug-just-because-it's-dangerous attitude hurt. In 2007, it approved Risperdal for adolescents 13-17 with schizophrenia and children and adolescents 10-17 with "short-term treatment of bipolar mania associated with manic or mixed episodes of bipolar I disorder" on the basis of two six to eight week studies. In fact the FDA was surprised when a panel of drug experts called together in November unanimously rejected its routine safety monitoring for Risperdal and related drugs for children out of hand. "I’m a little puzzled about the statement that the label is inadequate," said Dr. Thomas Laughren, director of the agency's division of psychiatry products according to the New York Times. "I’m anxious to hear what more we can do." How about not approving a drug in the first place? Martha Rosenberg is a columnist/cartoonist who writes about public health. She can be reached at martharosenberg@sbcglobal.net
|
Now Available from CounterPunch Books! Waiting for
Lightning
|